نتائج البحث - "MADROSZYK A"

1

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

المصدر: The Lancet Oncology. 21:1224-1233

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Adolescent, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Population, Disease-Free Survival, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, Etoposide, Aged, Chemotherapy, education.field_of_study, business.industry, Combination chemotherapy, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Topotecan, France, Neoplasm Recurrence, Local, business, Febrile neutropenia, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b2892288de0f63aa230ce4a3c45fe6Test
https://doi.org/10.1016/s1470-2045Test(20)30461-7

2

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)

المؤلفون: Jacques Le Treut, Catherine Dubos-Arvis, O. Bylicki, Alain Vergnenegre, Jacky Crequit, Marie Marcq, Gwenaelle Le Garff, Nicolas Paleiron, Victor Basse, Isabelle Monnet, Pascal Thomas, Gislaine Fraboulet, Bénédicte Comet, Anne Madroszyk, Jean-Bernard Auliac

المصدر: Cancer Management and Research. 11:10821-10826

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b4dc334dd9dfaa6871f5f7217af11d1bTest
https://doi.org/10.2147/cmar.s219984Test

3

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial 'at progression' cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

المؤلفون: Anne Marie Chiappa, Isabelle Monnet, Radj Gervais, Christos Chouaid, Alain Vergnenegre, S. Vieillot, Jean Bernard Auliac, Roland Schott, Gilles Robinet, Laurent Greillier, Lionel Falchero, Anne Madroszyk, R. Lamy, Pascal Thomas, Charles Ricordel, Samir Abdiche, Stephane Chouabe, Henri Berard, Chantal Decroisette

المساهمون: CHI Créteil, CHU Limoges, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hopital d'instruction des armées Sainte-Anne [Toulon] (HIA), Groupe Hospitalier Bretagne Sud (GHBS), Centre Paul Strauss, CRLCC Paul Strauss, CHU Pontchaillou [Rennes], Centre Hospitalier de Charleville-Mezières, Hôpital de GAP, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Libourne, CH de Quimper, Hôpital Nord [CHU - APHM]

المصدر: Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, SAGE Journals, 2021, 13, pp.175883592110069. ⟨10.1177/17588359211006983⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, non-small–cell lung cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, bevacizumab, Asymptomatic, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Lung cancer, pemetrexed, radiotherapy, RC254-282, cerebral metastasis, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Carboplatin, Radiation therapy, 030104 developmental biology, Pemetrexed, chemistry, 030220 oncology & carcinogenesis, medicine.symptom, business, management, medicine.drug, Brain metastasis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ff0277eb53f2530508c3b2d27143d2Test
https://doaj.org/article/a1b5190caa744a0094132ccad24a69d7Test

4

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

المؤلفون: Philippe Rochigneux, Alejandro J. Garcia, Brice Chanez, Anne Madroszyk, Daniel Olive, Edward B. Garon

المساهمون: Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU)

المصدر: Frontiers in Immunology
Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.01036⟩
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.01036⟩
Frontiers in Immunology, Vol 11 (2020)

مصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, 0301 basic medicine, Lung Neoplasms, immune monitoring, medicine.medical_treatment, Immunology, Antineoplastic Agents, Review, chemotherapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Monitoring, Immunologic, medicine, Biomarkers, Tumor, Immunology and Allergy, Humans, Mass cytometry, Molecular Targeted Therapy, Lung cancer, Immune Checkpoint Inhibitors, ComputingMilieux_MISCELLANEOUS, business.industry, Immunotherapy, medicine.disease, Immune checkpoint, 3. Good health, Biomarker (cell), lung cancer, 030104 developmental biology, Treatment Outcome, DNA methylation, Cancer research, [SDV.IMM]Life Sciences [q-bio]/Immunology, immunotherapy, lcsh:RC581-607, business, immune biomarker, 030215 immunology